Friday, November 20, 2026 Editions
Latest
Trending
US

Congress Top Doctor Resigns as Pentagon Watchdog Finds Medical Office Ran Without Proper Oversight

Rear Adm. Brian Monahan, the attending physician for Congress and the Supreme Court since 2009, has resigned amid misconduct investigations. A Defense Department inspector general report released on Friday found that no part of the Defense Department properly oversaw his office, its clinical care or its pharmacy.

Read inENESNEHIFR
Congress Top Doctor Resigns as Pentagon Watchdog Finds Medical Office Ran Without Proper Oversight
Photo: Uniformed Services University of the Health Sciences (usuhs.mil), Public domain, via Wikimedia Commons (https://commons.wikimedia.org/wiki/File:Brian_Monahan.JPG)

Key points

  • Rear Adm.
  • The Office of the Attending Physician provides medical care to members of Congress and their staff, and to the justices of the Supreme Court.
  • "The absence of [DoD] oversight of clinical quality management and pharmacy operations increases the risks to both patients and Navy medical personnel assigned to the OAP," the inspector general…

Rear Adm. Brian Monahan, the attending physician of the United States Congress, has resigned amid military investigations into allegations of misconduct, according to U.S. officials cited by The Wall Street Journal. The Pentagon Office of Inspector General released its findings on Friday, November 13, 2026, and warned of health and safety risks in the office Monahan had led since 2009.

The Office of the Attending Physician provides medical care to members of Congress and their staff, and to the justices of the Supreme Court. Monahan, a two-star Navy admiral, took the post in January 2009 after President Barack Obama nominated him. Senate Majority Leader John Thune confirmed the departure to The Washington Sun, saying: "My understanding is he's resigned." Neither Monahan nor the Navy had announced it, and the Navy website still listed him as attending physician.

What the watchdog found

"The absence of [DoD] oversight of clinical quality management and pharmacy operations increases the risks to both patients and Navy medical personnel assigned to the OAP," the inspector general report said. Investigators found improper quality management in patient care and in the pharmacy inventory, and traced the problems to a lack of oversight. The report said no wing of the Defense Department believes it has the authority to oversee clinical quality management and pharmaceutical care inside the office.

The pharmacy drew the sharpest findings. Investigators found no verifying evidence that the office pharmacy had passed the inspections or inventory checks federal law requires for controlled substances, and neither the Drug Enforcement Administration nor the Defense Department had visited it. The office invited Walter Reed's Controlled Substance Inventory Board to observe its inventory seven times between January 2023 and February 2026, short of the mandatory number. The board found five medication inconsistencies, among them missing prescription records in medical travel bags, and investigators could not verify whether the errors had been fixed. The Wall Street Journal reported that a February 2026 inventory found discrepancies in five controlled substances, including opioid pain medication. U.S. officials told the Journal the allegations against Monahan include managing a toxic work environment and dispensing medications to lawmakers and staff without prescriptions. The allegations have not been proven.

An investigation that hit a wall

The inspector general announced the evaluation in September 2025. Investigators interviewed former and current Defense Department personnel and reviewed hotline complaints from August 2023 to January 2026. Monahan recused himself, pointed investigators to a congressional counsel, and refused to participate. On March 9, 2026, investigators asked him to help arrange contact with another person in the office. The next day, the House deputy general counsel said Navy personnel in the office could not speak without the approval of Congress. A final request for records and interviews, on August 13, 2026, was denied again. Investigators could not access quality policies, pharmacy procedures, prescription records, climate assessments or internal peer reviews.

What happens next

The inspector general recommended that the Defense Department appoint a body to oversee the office medical personnel and coordinate with the House and Senate. It also recommended a review of pharmacy inspection records and a possible new inspection of the pharmacy. The resignation comes about a year after the Pentagon watchdog and the Navy opened their probes, U.S. officials told the Journal. The office was created in December 1928, and a Navy physician has always held the post.

Timeline

  1. Jan 2009Brian Monahan takes the post of attending physician of Congress after President Barack Obama nominates him.
  2. Sep 2025The Pentagon inspector general announces an evaluation of the Office of the Attending Physician.
  3. Feb 2026A Controlled Substance Inventory Board review finds discrepancies in the inventories of five controlled substances, including opioid pain medication, The Wall Street Journal reported.
  4. Mar 9, 2026Investigators ask Monahan to help arrange contact with another person in his office. The next day, the House deputy general counsel says Navy personnel in the office cannot speak without approval from Congress.
  5. Aug 13, 2026The House deputy general counsel denies the inspector general a final request for office records and interviews with office personnel.
  6. Nov 13, 2026The inspector general releases its findings on Friday. Monahan is reported to have resigned this week amid misconduct investigations.

Sources